Atrial fibrillation (AF) and flutter

Slides:



Advertisements
Similar presentations
Atrial Fibrillation Cardiovascular ISCEE 26th October 2010.
Advertisements

UCLA Family Medicine Department IMG Program Carlos Yoo.
New Atrial Fibrillation/Flutter Pathway and GRASP Tool
Emergency/Urgent Referral* (3) -Pt acutely unwell with palpitations -Pt with haemodyanically unstable acute onset AF -2 nd /3 rd heart block -Exercise.
Atrial fibrillation Cardiology #2 Gimadeeva A.D..
Cardiovascular 2 Phase 2 Michelle Mair
Atrial fibrillation.
ATRIAL FIBRILLATION Linda A. Snyder, MSN, CRNP. Definition: A common arrhythmia characterized by chaotic, rapid, discontinuous atrial depolarizations.
Cardiac Arrhythmia. Cardiac Arrhythmia Definition: The pumping action of the heart is coordinated by an electrical system within the heart tissue.
Atrial Flutter Chris Caulfield AM Report 2/19/10.
Atrial fibrillation Daniel Gutenberger M.D. Chief Medical Director American General, Milwaukee.
Arrhythmias: The Good, the Bad and the Ugly
Atrial Fibrillation. Outline Epidemiology Signs and Symptoms Etiology Differential Diagnosis Diagnostic Tests Classification Management.
Atrial Fibrillation Steve McGlynn
Atrial Fibrillation Steve McGlynn Specialist Principal Pharmacist (Cardiology), Greater Glasgow and Clyde Honorary Clinical Lecture, University of Strathclyde.
Arrhythmias Danny Haywood FY1.
Atrial Fibrillation. Statistics 1.5% of people over 65 have AF 1.5% of people over 65 have AF 5x increased risk of stroke 5x increased risk of stroke.
Atrial Fibrillation.
Arrhythmia recognition and treatment
Sinus, Atrial, Junctional / Nodal, Ventricular, Blocks, others.
Cardiac Arrhythmias in Coronary Heart Disease SIGN 94.
Yasmine Darwazeh FY1 – General Surgery
Dr Avinash Haridas Pillai
Secondary prevention after a TIA or ischemic stroke.
European Heart Journal 2010 European Heart Rhythm Association (EHRA); Endorsed by the European Association for Cardio-Thoracic.
Atrial Fibrillation Dr Nidhi Bhargava 8/10/13.
Atrial Fibrillation Rate or rhythm control? Who should be anticoagulated? Other treatment strategies.
Perioperative management of atrial fibrillation
Atrial Fibrillation Andreas Stein Robert Smith, M.D. August 11, 2003.
Atrial Fibrillation Current Management Strategies.
Supraventricular Arrhythmias Claire B. Hunter, M.D.
Mitral Valve Disease Prof JD Marx UFS January 2006.
Atrial Fibrillation DR. DAYANAND NAIK, MD, FACC; CLINICAL ASSOCIATE PROFESSOR, NEW YORK MEDICAL COLLEGE.
ELECTROCARDIOGRAPHIC MONITORING Various rhythms and dysrhythmias: Ventricular Fibrillation Ventricular Tachycardia Atrial Fibrillation Atrial Flutter Supraventricular.
#1009 Evaluation & Management of Atrial Fibrillation November 16 to 19 Stephen F. Schaal, MD Professor of Internal Medicine Division of Cardiology The.
By Dr. Zahoor CARDIAC ARRHYTHMIA.
ARRHYTHMIA. Disturbance of cardiac rythumn Anatomy of the conducting system.
Treatment of Atrial Fibrillation M Samson – PGY-2 Riverside Campus July 17, 2015 Academic Day.
Applied Therapeutics Dr. Riyadh Mustafa Al-Salih
Arrhythmias Disturbance of heart rhythm and/or conduction. ot.com.
1 AF: Issues with Anticoagulation AFL: Anticoagulation like AF When undergoing procedures with risk for bleeding: May DC warfarin for up to one week without.
The Case for Rate Control: In the Management of Atrial Fibrillation Charles W. Clogston, M.D. Cardiologist CHI St. Vincent Heart Clinic Arkansas April.
Palpitations & Atrial Fibrillation Dr Mehul B Dhinoja, Consultant Cardiologist & Electrophysiologist BMI The London Independent Hospital.
Atrial Fibrillation: An old age problem PCCS Village Hotel 18 th May 2011.
Atrial Fibrillation Jay H. Lee, MD Denver Health Medical Center Wednesday 2 July 2008.
Tachykardie / bradykardie
Contemporary Atrial Fibrillation Management
ECG Michael Watts
Atrial fibrillation J Heinsimer MD.
Zoll Firm Lecture Series
HESS 509 Atrial Fibrillation CHAPTER ELEVEN
Warfarin in primary care
AF Basics for Office Visits Patient Education
Conduction Disturbances: Cardiac Arrhythmias and Heart Block
Antithrombotic Therapy in Atrial Fibrillation
Cariovascular pharmacology for primary care physician: cardiotonics, antiarrhytmics, vasodilatators Domina Petric, MD.
AF in 2014 Dr Stewart Healy.
Basic Telemetry Course
Applied Therapeutics Dr. Riyadh Mustafa Al-Salih
Use of NOACs is contraindicated for AF patients with mechanical prosthetic valves or moderate- severe mitral stenosis (usually of rheumatic origin). Although.
2014 AATS guidelines for the prevention and management of perioperative atrial fibrillation and flutter for thoracic surgical procedures. Executive summary 
Arrhythmias introduction
Narrow complex tachycardia
Broad complex tachycardia
تهيه كننده : علي اكبر اكبر پور سوپروایزر آموزشی – دبیر طرح تحول سلامت
Fibrillazione atriale
Ann Parker Cardiology Pharmacist Frimley Health
2014 AATS guidelines for the prevention and management of perioperative atrial fibrillation and flutter for thoracic surgical procedures  Gyorgy Frendl,
NICE 2014 Check pulse in patients presenting with:
ELECTROCARDIOGRAPHIC MONITORING
Presentation transcript:

Atrial fibrillation (AF) and flutter Domina Petric, MD

Atrial fibrillation Chaotic, irregular atrial rhythm at 300-600 bpm. The AV node responds intermittently: irregular ventricular rate. Cardiac output drops by 10-20%. AF is common in the elderly. The main risk is embolic stroke.

AF causes heart failure heart ischaemia arterial hypertension myocardial infarction pulmonary embolism mitral valve disease pneumonia

AF causes hyperthyroidism caffeine alcohol post-operative AF hypokalemia hypomagnesemia

AF causes cardiomyopathy constrictive pericarditis sick sinus syndrome lung carcinoma atrial myxoma endocarditis haemochromatosis idiopatic

Symptoms asymptomatic chest pain palpitations dyspnoea faintness

Signs Irregularly irregular pulse! The apical pulse is greater than the radial rate. First heart sound is of variable intensity. There may be signs of left ventricular failure.

Image source: Lifeinthefastlane.com Absent P waves, irregular QRS complexes.

Blood tests Urea, electrolytes, kreatinine Cardiac enzymes Thyroid function tests

Other tests Echocardiography: left atrial enlargement, mitral valve disease, poor left ventricle function and other structural abnormalities.

Conversion of atrial fibrillation Within 48 hours from acute onset, propafenone 600 mg per os in patients without structural heart disease. Within 48 hours, amiodarone 300 mg per os in patients with structural heart disease. Electrocardioversion!

Conversion of atrial fibrillation >48 hours Immediate electrocardioversion: transesophageal echocardiography + 5000 IJ LMWH OR Electrocardioversion after 3 weeks of warfarin therapy.

Conversion of atrial fibrillation Immediate electrocardioversion after period of 48 hours can be done only if transoesophageal echocardiography shows that the heart is thrombus free.

Alternative drug cardioversion Amiodarone iv. 5 mg/kg over 1 h, then 900 mg over 24 hours via a central line. Amiodarone 200 mg every 8 hours for 1 week, 200 mg every 12 hours next week and 100-200 mg every 24 hours as a maintenance therapy. Flecainide 2 mg/kg iv. over 10-30 minutes, max. 150 mg OR 300 mg per os.

Flecainide It can be used only if the patient is stable and there is no known ischaemic heart disease or Wolff-Parkinson-White syndrome.

Chronic AF Main goals are: rate control anticoagulation

Rate control Beta blocker (BB) or rate-limiting Ca-blocker (CB). Alternatives are digoxin and amiodarone. BB should not be combined with diltiazem and verapamil!

Rhythm control Rhythm control is prefered in: symptomatic patients congestive cardiac failure younger patients patients presenting for the first time with lone AF AF from a corrected precipitant (electrolytes disbalance)

Rhythm control Electrocardioversion! Pharmacological cardioversion! AV node ablation! Maze procedure! Pacing! Pulmonary vein ablation!

Acute anticoagulation LMWH in preparation for electrocardioversion. Warfarin can also be used for elective electrocardioversion preparation.

Chronic anticoagulation Anticoagulation with warfarin to aim for an INR 2-3. Aspirin 300 mg per os can be used in patients with contraindications for warfarine use with very low risk of emboli. Very low risk include younger than 65 years, NO hypertension, diabetes, LV dysfunction, rheumatic valve disease. past MI or TIA.

Contraindications for warfarin bleeding diathesis platelets <50 x 109/L compliance issues frequent falls NSAID use past intracranial bleeds low haemoglobin

Chronic anticoagulation Dabigatran is a direct thrombin inhibitor. There is no need for regular laboratory INR monitoring and dose adjustment. Dose is 110 mg every 12 hours per os. Contraindications for dabigatran are severe renal and liver impairment, active bleeding, lesion at risk of bleeding, low level of clotting factors.

Interactions with dabigatran heparin clopidogrel NSAIDS GPIIb/IIIa antagonists p-glycoprotein inhibitors like verapamil, amiodarone, clarithromycin

Atrial flutter ECG: continous atrial depolarisation, heart rate usually 300 bpm, but very variable, sawtooth baseline and 2:1 AV block.

Lifeinthefastlane.com

Treatment Anticoagulation and electrocardioversion Amiodarone, sotalol or BB Cavotricuspid isthmus ablation

Literature Oxford Handbook of Clinical Medicine. Longmore M. Wilkinson I. B. Baldwin A. Elizabeth W. Ninth edition. Lifeinthefastlane.com